380 related articles for article (PubMed ID: 9560829)
1. Managing patients with vulvovaginal candidiasis.
Elliott KA
Nurse Pract; 1998 Mar; 23(3):44-6,49-53. PubMed ID: 9560829
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent vulvovaginal candidiasis.
Ringdahl EN
Am Fam Physician; 2000 Jun; 61(11):3306-12, 3317. PubMed ID: 10865926
[TBL] [Abstract][Full Text] [Related]
3. [Recurrent vulvovaginal mycoses].
Salvat J; Romand P; Vincent-Genod A; Younes B; Guilbert M
Rev Fr Gynecol Obstet; 1995 Nov; 90(11):494-501. PubMed ID: 8638082
[TBL] [Abstract][Full Text] [Related]
4. Recurrent vulvovaginal candidiasis.
Ringdahl EN
Mo Med; 2006; 103(2):165-8. PubMed ID: 16703718
[TBL] [Abstract][Full Text] [Related]
5. Recurrent vulvovaginal candidiasis.
MacNeill C; Carey JC
Curr Womens Health Rep; 2001 Aug; 1(1):31-5. PubMed ID: 12112949
[TBL] [Abstract][Full Text] [Related]
6. Candicidin for vaginal candidiasis.
Med Lett Drugs Ther; 1972 Nov; 14(23):86-8. PubMed ID: 4567568
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
8. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
Donders G; Bellen G; Byttebier G; Verguts L; Hinoul P; Walckiers R; Stalpaert M; Vereecken A; Van Eldere J
Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
[TBL] [Abstract][Full Text] [Related]
9. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.
Ventolini G; Baggish MS; Walsh PM
J Reprod Med; 2006 Jun; 51(6):475-8. PubMed ID: 16846086
[TBL] [Abstract][Full Text] [Related]
10. [Vaginal candidiasis--treatment protocols using miconazole and fluconazole].
Mazneĭkova V
Akush Ginekol (Sofiia); 2003; 42 Suppl 2():30-4. PubMed ID: 14619753
[TBL] [Abstract][Full Text] [Related]
11. [Vulvovaginal mycoses].
Mendling W
Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):175-9. PubMed ID: 9606884
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India.
Ahmad A; Khan AU
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):68-71. PubMed ID: 19261369
[TBL] [Abstract][Full Text] [Related]
13. Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis.
Friese K; Neumann G; Siebert J
Arch Gynecol Obstet; 2003 Aug; 268(3):194-7. PubMed ID: 12942250
[TBL] [Abstract][Full Text] [Related]
14. Vulvovaginal candidiasis: a current update.
Carcio HA; Secor RM
Nurse Pract Forum; 1992 Sep; 3(3):135-44. PubMed ID: 1472885
[TBL] [Abstract][Full Text] [Related]
15. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
16. [Vulvovaginal candidiasis: a therapeutic approach].
Battaglia F; Mariani L; Anglana F; Milite V; Quattrini M; Plotti F; Tomao F; Plotti G
Minerva Ginecol; 2005 Apr; 57(2):131-9. PubMed ID: 15940073
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
18. Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group.
Brown D; Henzl MR; Kaufman RH
J Reprod Med; 1999 Nov; 44(11):933-8. PubMed ID: 10589403
[TBL] [Abstract][Full Text] [Related]
19. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
20. Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy.
Meyer H; Goettlicher S; Mendling W
Mycoses; 2006 May; 49(3):202-9. PubMed ID: 16681811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
